<DOC>
	<DOCNO>NCT01904032</DOCNO>
	<brief_summary>This randomize clinical trial ( RCT ) determine effectiveness vitamin D3 supplementation depressive symptom , self-management , blood pressure approximately 180 adult woman type 2 diabetes significant depressive symptom . Consenting adult woman eligible participate randomly assign either weekly dose 50,000 international unit vitamin D3 supplementation match weekly active comparator 5,000 international unit vitamin D3 six month . Participants complete approximately four in-person study visit several telephone visit throughout six month trial period , researcher assess depressive symptom , diabetes self-management , systolic blood pressure . Aim 1 : To determine effect vitamin D supplementation depressive symptom ( primary outcome ) , self-management ( secondary outcome ) , systolic blood pressure ( exploratory outcome ) compare placebo . Hypothesis : Women receive vitamin D supplementation report few depressive symptom , increase diabetes self- management mediate depression improvement , low systolic blood pressure compare take placebo three six month follow-up . Aim 2 : To explore mechanistic effect vitamin D supplementation inflammatory biomarkers association depression . Hypothesis : Women receive vitamin D supplementation decrease inflammatory biomarkers associate few depressive symptom compare take placebo three six month follow-up</brief_summary>
	<brief_title>Sunshine 2 Study Women With Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Women age 21 old Objective evidence depressive symptom screen baseline visit Diagnosis type 2 diabetes currently treat healthcare provider Blood vitamin D level le 32 nanogramsperdeciliter ( 32 ng/dl ) Current alcohol substance use disorder Any unstable severe psychiatric disease include diagnosis schizophrenia , bipolar affective disorder , dementia , delirium , psychotic disorder Severe complication diabetes , blindness and/or amputation Any malabsorption disorder , Crohn 's disease and/or celiac sprue Elevated serum calcium level deem significant Principal Investigator Use 1,000 international unit daily vitamin D 60 day enrollment unwillingness discontinue vitamin D supplementation 30 day enrollment . Use St. John 's Wort unwillingness discontinue St. John 's Wort three week prior enrollment . Participants pregnant , nursing , plan become pregnant study . Baseline systolic blood pressure ( SBP ) great 160 millimeter mercury ( mmHG ) diastolic blood pressure ( DBP ) great 100 mmHG . Other serious medical condition ( e.g. , cancer , multiple sclerosis , etc . ) deem clinically significant Principal Investigator</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Self-Management</keyword>
	<keyword>Depression</keyword>
	<keyword>Women</keyword>
</DOC>